The U.S. International Trade Commission drew a line under a contentious chapter in the Apple-Masimo patent war on April 17, 2026. By declining to review an administrative law judge’s finding of no infringement, the ITC terminated proceedings against Apple’s redesigned Apple Watches. This move clears the path for continued U.S. sales of models featuring the blood-oxygen capability. Masimo’s push to revive an import ban—rooted in disputes over pulse oximetry tech—fell short. Administrative Law Judge Monica Bhattacharyya had ruled on March 18 that Apple’s updates sidestepped Masimo’s patents. Both sides petitioned for review. The commission said no. ‘This combined proceeding is hereby terminated in its entirety with the conclusion that the accused redesigned products do not infringe the Asserted Patents,’ the ITC stated in its order, as reported by 9to5Mac . Apple wasted no time celebrating.…